Screening of blood donors for chronic Coxiella burnetii infection after large Q fever outbreaks

Transfusion

Volumn 54, Issue 11, 2014, Pages 2867-2870

  Slot, Ed ^a   Hogema, Boris M ^a   Molier, Michel ^a   Zaaijer, Hans L ^a,b  

^a CENTRAL LABORATORY   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; COXIELLA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SCREENING; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD DONOR; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; DONOR SELECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NETHERLANDS; Q FEVER; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SERUM; YOUNG ADULT; ADOLESCENT; BLOOD; CLINICAL TRIAL; COXIELLA BURNETII; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; TRANSMISSION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; BLOOD DONORS; COXIELLA BURNETII; DISEASE OUTBREAKS; DONOR SELECTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; Q FEVER;

EID: 84912525507     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12749     Document Type: Article

References (15)

1. van der Hoek W, Dijkstra F, Schimmer B, et al. Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill 2010; 15: 19520.
2. Roest HI, Tilburg JJ, van der Hoek W, et al. The Q fever epidemic in The Netherlands: history, onset, response and reflection. Epidemiol Infect 2011; 139: 1-12.
3. Dijkstra F, van der Hoek W, Wijers N, et al. The 2007-2010 Q fever epidemic in The Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming. FEMS Immunol Med Microbiol 2012; 64: 3-12.
4. Wegdam-Blans MC, Stokmans RA, Tjhie JH, et al. Targeted screening as a tool for the early detection of chronic Q fever patients after a large outbreak. Eur J Clin Microbiol Infect Dis 2013; 32: 353-359.
5. Wegdam-Blans MC, Kampschreur LM, Delsing CE, et al. Chronic Q fever: review of the literature and a proposal of new diagnostic criteria. J Infect 2012; 64: 247-259.
6. Kampschreur LM, Oosterheert JJ, Koop AM, et al. Microbiological challenges in the diagnosis of chronic Q fever. Clin Vaccine Immunol 2012; 19: 787-790.
7. Kampschreur LM, Wever PC, Wegdam-Blans MC, et al. Defining chronic Q fever: a matter of debate. J Infect 2012; 65: 362-363.
8. Kampschreur LM, Dekker S, Hagenaars JC, et al. Identification of risk factors for chronic Q fever, the Netherlands. Emerg Infect Dis 2012; 18: 563-570.
9. van der Hoek W, Schneeberger PM, Oomen T, et al. Shifting priorities in the aftermath of a Q fever epidemic in 2007 to 2009 in The Netherlands: from acute to chronic infection. Euro Surveill 2012; 17: 20059.
10. Hogema BM, Slot E, Molier M, et al. Coxiella burnetii infection among blood donors during the 2009 Q-fever outbreak in the Netherlands. Transfusion 2012; 52: 144-150.
11. Van Wijk MJ, Maas DW, Renders NH, et al. Screening of post-mortem tissue donors for Coxiella burnetii infection after large outbreaks of Q fever in The Netherlands. BMC Infect Dis 2014; 14: 6.
12. Herremans T, Hogema BM, Nabuurs M, et al. Comparison of the performance of IFA, CFA, and ELISA assays for the serodiagnosis of acute Q fever by quality assessment. Diagn Microbiol Infect Dis 2013; 75: 16-21.
13. Anonymous. Q-fever transmitted by blood transfusion-United States. CDC public health notes 1977.
14. van Kraaij MG, Slot E, Hogema BM, et al. Lookback procedures after postdonation notifications during a Q fever outbreak in the Netherlands. Transfusion 2013; 53: 716-721.
15. Commission of the European Communities. Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components. OJ 2004; L91: 25-39.